Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Soligenix Inc. September 17, 202690.6%
-
Kura Oncology Inc. June 4, 202675.1%
-
Celularity Inc. December 19, 202531.4%
-
Soligenix Inc. June 20, 202590.8%
-
Soligenix Inc. May 30, 202485.1%
-
Soligenix Inc. December 15, 202367.0%
-
Kura Oncology Inc. May 31, 202372.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Celularity Inc. | Grant or award | +30,000 | — | — |
| Dec 29, 2025 | Celularity Inc. | Grant or award | +125,000 | — | — |
| Dec 19, 2025 | Celularity Inc. | Grant or award | +67,416 | — | — |
| Nov 19, 2025 | Celularity Inc. | Grant or award | +61,539 | — | — |
| Dec 19, 2024 | Celularity Inc. | Grant or award | +67,416 | — | — |
| Jun 14, 2023 | Celularity Inc. | Grant or award | +199,921 | — | — |
Questions about Diane L. Parks
What boards is Diane L. Parks on?
Diane L. Parks sits on the boards of Celularity Inc., Kura Oncology Inc. and Soligenix Inc.
How long has Diane L. Parks served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.